Literature DB >> 23799281

Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans.

Derek J Roberts1, Craig N Jenne, Caroline Léger, Andreas H Kramer, Clare N Gallagher, Stephanie Todd, Ian F Parney, Christopher J Doig, V Wee Yong, Paul Kubes, David A Zygun.   

Abstract

An increasing number of preclinical investigations have suggested that the degree of expression of the matrix metalloproteinase (MMP) family of endopeptidases may explain some of the variability in neurological damage after traumatic brain injury (TBI). As cytokines are a prominent stimulus for MMP expression in animals, we conducted a prospective multimodal monitoring study and determined their association with temporal MMP expression after severe TBI in eight critically ill adults. High cutoff, cerebral microdialysis (n=8); external ventricular drainage (n=3); and arterial and jugular venous bulb catheters were used to measure the concentration of nine cytokines and eight MMPs in microdialysate, cerebrospinal fluid (CSF), and plasma over 6 days. Severe TBI was associated with a robust central inflammatory response, which was largely similar between microdialysate and CSF. At all time points after injury, this response was predominated by the pro-inflammatory cytokines interleukin-6 (IL-6) and IL-8. Use of univariate generalized estimating equations suggested that the concentration of several MMPs varied with cytokine levels in microdialysate. The largest of these changes included increases in microdialysate concentrations of MMP-8 and MMP-9 with increases in the levels of IL-1α and -2 and IL-1α and -2 and TNF-α, respectively. In contrast, the microdialysate level of MMP-7 decreased with increases in microdialysate concentrations of IL-1β, -2, and -6. These findings support the observations of animal studies that cross-talk exists between the neuroinflammatory and MMP responses after acute brain injury. Further study is needed to determine whether this link between cerebral inflammation and MMP expression may have clinical relevance to the care of patients with TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23799281     DOI: 10.1089/neu.2012.2842

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  22 in total

Review 1.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

Review 2.  The Influence of Systemic Immune Response and Sleep Modulation on the Secondary Effects of Traumatic Brain Injury in the Rodent Model.

Authors:  Carrie A Sheeler
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

3.  IL-6 regulation of synaptic function in the CNS.

Authors:  Donna L Gruol
Journal:  Neuropharmacology       Date:  2014-11-22       Impact factor: 5.250

4.  Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?

Authors:  Colin Casault; Abdulaziz S Al Sultan; Mohammad Banoei; Philippe Couillard; Andreas Kramer; Brent W Winston
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 5.  Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid.

Authors:  Marie-Laure Custers; Liam Nestor; Dimitri De Bundel; Ann Van Eeckhaut; Ilse Smolders
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 6.  Monitoring inflammation (including fever) in acute brain injury.

Authors:  J Javier Provencio; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 7.  Clinical evidence of inflammation driving secondary brain injury: a systematic review.

Authors:  Holly E Hinson; Susan Rowell; Martin Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2015-01       Impact factor: 3.313

Review 8.  Traumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injury.

Authors:  Hanna Algattas; Jason H Huang
Journal:  Int J Mol Sci       Date:  2013-12-30       Impact factor: 5.923

Review 9.  Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.

Authors:  P M Abdul-Muneer; Bryan J Pfister; James Haorah; Namas Chandra
Journal:  Mol Neurobiol       Date:  2015-11-05       Impact factor: 5.682

10.  Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.

Authors:  Bridgette D Semple; Linda J Noble-Haeusslein; Major Gooyit; Kayleen G Tercovich; Zhihong Peng; Trung T Nguyen; Valerie A Schroeder; Mark A Suckow; Mayland Chang; Jacob Raber; Alpa Trivedi
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.